COMMUNIQUÉS West-GlobeNewswire

CTD Holdings to Present at UK Annual Conference for NPC Patients, Families, and Health Professionals

13/09/2018 - 16:56

Conference Brings the NPC community together for scientific exchanges and information sharing with NPC families ALACHUA, Fla., Sept. 13, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage [...]

PCI Biotech: Disclosure of voting rights for Chairman of the Board

13/09/2018 - 16:40

Oslo, 13 September 2018. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall open the [...]

CARsgen Therapeutics et CrownBio achèvent une étude sur les cellules CAR-T pour le cancer de l’estomac

13/09/2018 - 16:03

Des cellules CAR-T spécifiques de la claudine 18.2 montrent une élimination tumorale dans les modèles de xénogreffe SAN DIEGO, 13 sept. 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, une société mondiale de services de [...]

ABclonal Technology Unveils Next-Generation Sequencing Kits for Illumina Sequencing Platforms

13/09/2018 - 16:00

New Line of DNA- and RNA-Sequencing Library Preparation Kits Produce Highest Library Yield While Maintaining Quality During Sample Preparation BOSTON, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ABclonal Technology, a dynamic [...]

Bhang Announces Strategic Brand Alliances to Strengthen California Cannabis Footprint

13/09/2018 - 15:45

New Partnerships Highlight Bhang’s Focus on Leading the Expanding Cannabis Marketplace Starting in California MIAMI, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Bhang Corporation announced today that it hired top Los Angeles [...]

Medtronic Recognized for Its Sustainability Leadership

13/09/2018 - 15:01

Company Marks its Eleventh Consecutive Year on the North American Dow Jones Sustainability Index (DJSI) DUBLIN - September 13, 2018 - Medtronic plc (NYSE:MDT) was recognized today as one of the world's leading companies [...]

BioSyent Named to the Growth 500 Ranking of Canada's Fastest-Growing Companies for Sixth Consecutive Year

13/09/2018 - 15:00

TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been named to the annual Growth 500 ranking of Canada’s Fastest-Growing Companies by Canadian [...]

AXIM® Biotechnologies Signs LOI for Distribution of Products Throughout Australia and New Zealand

13/09/2018 - 15:00

Leading Cannabinoid Biotech Company Signs Letter of Intent with Leading Australian Healthcare Company for Development of New Products and Assistance with Obtaining Regulatory Approval NEW YORK, Sept. 13, 2018 (GLOBE [...]

Positive Afrezza® Clinical Data from STAT Study Published in Diabetes Technology & Therapeutics

13/09/2018 - 15:00

Study data show Afrezza provides greater improvement in postprandial glucose control than insulin aspart WESTLAKE VILLAGE, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) announced today [...]

IlluminOss Medical Receives Clearance to Expand Clinical Indications in the U.S.

13/09/2018 - 15:00

Secures FDA Clearance for the Treatment of Traumatic, Fragility, Pathological and Impending Fractures EAST PROVIDENCE, R.I. , Sept. 13, 2018 (GLOBE NEWSWIRE) -- IlluminOss Medical , a privately held, commercial-stage [...]

Veritas Enters Into LOI for Sale of Sechelt Organic Marijuana

13/09/2018 - 15:00

VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that the Company has entered into a [...]

Correction in Announcement of JSC Olainfarm: the Council of the company has been elected legally and works for the long-term interests of the company

13/09/2018 - 14:49

Correction in the 3rd paragraph of the Announcement: Word "the stock exchange" has been replaced with the word "the market", to clarify the message. The new council of JSC Olainfarm has been elected legally, represents [...]

FIT Biotech Oy: FIT Biotech withdraws a patent application

13/09/2018 - 14:46

FIT Biotech Oy Company release 13.9.2018 klo 3:45 PM EET FIT Biotech withdraws a patent application FIT Biotech Ltd ("Company", FITBIO: FN Finland) announced on 23rd of May 2018 that it filed two international patent [...]

Teladoc Health to Host Investor Day on September 27, 2018

13/09/2018 - 14:35

PURCHASE, NY, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will host its Investor Day on Thursday, September 27, 2018, in New York [...]

Todos Medical, Ltd. Signs Non-Binding Memorandum of Understanding with Orot+ for Distribution Rights of its Breast Cancer Screening Tests in Romania and Austria

13/09/2018 - 14:30

REHOVOT, Israel, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer, today [...]

Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative

13/09/2018 - 14:30

VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to report significant progress in applying the [...]

Assure Holdings Performs First Neuromonitoring Case in Pennsylvania

13/09/2018 - 14:30

Marks Assure’s Expansion into its Fifth State DENVER, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services [...]

VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals for As-Needed Treatment of Social Anxiety Disorder

13/09/2018 - 14:30

Phase 3-ready asset expands VistaGen’s CNS pipeline and complements its neuropsychiatry focus on Major Depressive Disorder (MDD) with AV-101 Novel PH94B nasal spray expected to enter pivotal Phase 3 development for as- [...]

SELLAS Receives Orphan Medicinal Product Designation Approval by the Committee for Orphan Medicinal Products of the European Medicines Agency for Galinpepimut-S for the Treatment of Patients with Multiple Myeloma

13/09/2018 - 14:30

NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]